Magnocavallo, Michele
 Distribuzione geografica
Continente #
NA - Nord America 550
EU - Europa 278
AS - Asia 112
SA - Sud America 5
AF - Africa 2
OC - Oceania 1
Totale 948
Nazione #
US - Stati Uniti d'America 543
IT - Italia 157
SG - Singapore 48
IN - India 46
SE - Svezia 41
BG - Bulgaria 20
FI - Finlandia 15
DE - Germania 10
RO - Romania 9
IE - Irlanda 7
HK - Hong Kong 6
TH - Thailandia 6
AR - Argentina 5
NL - Olanda 5
CA - Canada 4
CN - Cina 4
PL - Polonia 4
FR - Francia 3
GB - Regno Unito 3
UA - Ucraina 3
MX - Messico 2
TG - Togo 2
DO - Repubblica Dominicana 1
ID - Indonesia 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
Totale 948
Città #
Ashburn 82
Rome 65
Chandler 61
Fairfield 59
Princeton 32
San Paolo di Civitate 24
Millbury 23
Wilmington 21
Seattle 20
Singapore 20
Sofia 20
Woodbridge 15
Helsinki 14
San Diego 14
Lawrence 13
Andover 12
Houston 12
Cambridge 11
Pune 11
New York 10
Milan 9
Boardman 7
Dublin 7
Hong Kong 6
Amsterdam 5
Federal 5
Redwood City 5
Bologna 4
Norwalk 4
San Mateo 4
Straubenhardt 4
Toronto 4
Boston 3
Bühl 3
Guidonia Montecelio 3
Lariano 3
Matera 3
Ann Arbor 2
Biancavilla 2
Buffalo 2
Cagliari 2
Camponogara 2
Civitavecchia 2
Corteno Golgi 2
Fermignano 2
Fremont 2
Guardavalle 2
Laxou 2
Lomé 2
Mountain View 2
Sacramento 2
Accadia 1
Auckland 1
Austin 1
Azcapotzalco 1
Bangalore 1
Bari 1
Bergamo 1
Bussolengo 1
Chennai 1
Figline Valdarno 1
Frankfurt am Main 1
Fubine 1
Gela 1
Hangzhou 1
Jakarta 1
Lappeenranta 1
Las Vegas 1
London 1
Los Angeles 1
Marano Di Napoli 1
Marino 1
Milazzo 1
Mykolayiv 1
Oxford 1
Perugia 1
Plattsmouth 1
Recanati 1
Redmond 1
Richmond 1
San Pablo 1
Santo Domingo Este 1
Serra D'aiello 1
Shanghai 1
Shenzhen 1
Strumica 1
Verona 1
Vijayawada 1
Villanova 1
Wandsworth 1
Totale 685
Nome #
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis 56
Management of cardiac implantable electronic device follow-up in COVID-19 pandemic. Lessons learned during Italian lockdown 55
Potential role of eNOS genetic variants in ischemic heart disease susceptibility and clinical presentation 46
Adverse drug reactions during real-life use of direct oral anticoagulants in italy. An update based on data from the italian national pharmacovigilance network 43
Home delivery of the communicator for remote monitoring of cardiac implantable devices: a multicenter experience during the covid-19 lockdown 43
Flecainide how and when. a practical guide in supraventricular arrhythmias 43
Evidence of systemic endothelial injury and microthrombosis in hospitalized COVID-19 patients at different stages of the disease 42
Flecainide in ventricular arrhythmias. from old myths to new perspectives 40
Thromboembolic and bleeding risk in atrial fibrillation patients with chronic kidney disease: role of anticoagulation therapy 36
Sporadic high pacing and shock impedance on remote monitoring in hybrid implantable cardioverter-defibrillator systems: clinical impact and management 34
New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation 32
Incidence of Device-Related Thrombosis in Watchman Patients Undergoing a Genotype-Guided Antithrombotic Strategy 31
Prevalence and clinical Implications of COVID-19 myocarditis 28
A mobile app for improving the compliance with remote management of patients with cardiac implantable devices. a multicenter evaluation in clinical practice 28
Radiofrequency Energy Applications Targeting Significant Residual Leaks After Watchman Implantation: A Prospective, Multicenter Experience 27
Left atrial appendage exclusion in atrial fibrillation radiofrequency ablation during mitral valve surgery: a single-center experience 27
Clinical Support through Telemedicine in Heart Failure Outpatients during the COVID-19 Pandemic Period: Results of a 12-Months Follow Up 26
Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion 26
The scar. the wind in the perfect storm-insights into the mysterious living tissue originating ventricular arrhythmias 25
Reply to the editor-high subthreshold pacing impedance from device-lead connection issues 24
Clinical presentation, diagnosis, and treatment of atrioesophageal fistula resulting from atrial fibrillation ablation 24
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy 21
Impact of COVID-19 pandemic on cardiac electronic device management and role of remote monitoring 21
Predictive value of measures of vascular calcification burden and progression for risk of death in incident to dialysis patients 20
Catheter ablation of life-threatening ventricular arrhythmias in athletes 17
Procedural and Short-Term Follow-Up Outcomes of Amplatzer Amulet Occluder versus Watchman FLX Device: A Meta-Analysis 17
Ventricular electrograms duration map to detect ventricular arrhythmia substrate. the VEDUM project study 17
Targeting non-pulmonary vein triggers in persistent atrial fibrillation: results from a prospective, multicentre, observational registry 16
The scar: the wind in the perfect storm—insights into the mysterious living tissue originating ventricular arrhythmias 16
null 15
null 15
Prevalence, management, and outcome of atrial fibrillation and other supraventricular arrhythmias in COVID-19 patients 15
[Atrial fibrillation, oral anticoagulation and nephroprotection: caution or bravery?] 15
null 14
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy 14
Catheter Ablation For Papillary Muscle Arrhythmias A Systematic Review 14
Clinical Support through Telemedicine in Heart Failure Outpatients during the COVID-19 Pandemic Period: Results of a 12-Months Follow Up 13
null 13
null 11
Zero-Contrast Left Atrial Appendage Occlusion and Peridevice Leak Closure in Patients with Advanced Kidney Disease 10
Long-Term Clinical-Pathologic Results of Enzyme Replacement Therapy in Prehypertrophic Fabry Disease Cardiomyopathy 10
Vascular Calcification Progression Modulates the Risk Associated with Vascular Calcification Burden in Incident to Dialysis Patients 10
Rationale and study design of the Italian Registry in the setting of atrial fibrillation ablation with Rivaroxaban - IRIS 5
Modified sympathicotomy in patients with refractory ventricular tachycardia and structural heart disease: a single-center experience 2
Totale 1.057
Categoria #
all - tutte 5.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.290


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 3 12 19 4 15
2021/2022350 5 1 21 53 23 24 8 52 38 14 56 55
2022/2023329 59 53 9 20 38 24 19 21 45 12 25 4
2023/2024325 16 37 15 35 40 79 8 22 0 23 31 19
Totale 1.057